How Is The Market Feeling About Recursion Pharmaceuticals?
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
GEN11h
As Pipeline Advances, Recursion Expands AI Focus to Clinical Trials
Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.
Recursion Pharmaceuticals call volume above normal and directionally bullish
Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 16,974 calls trading, 1.0x expected, and implied vol increasing over 12 ...
Demystifying Knowledge Graphs: Unlocking The Power Of Connected Data
Understanding potential pitfalls—and how to overcome them—can help organizations maximize the value of this technology.
CHEQ Acquires Deduce, Expanding Go-To-Market Security Platform with Identity Graph for Human and AI-Generated Fraud Prevention
Pairing AI-driven, context-specific threat detection with identity intelligence to protect a wider range of attack vectors ...